Xiaobo He
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- RNA modifications and cancer 10
- Bone Metabolism and Diseases 8
- TGF-β signaling in diseases 4
- Oncology 21
- Bone health and treatments 4
- Co-authors
- Shaodong Hong (5 shared papers)Wenfeng Fang (4 shared papers)Jianhua Zhan (4 shared papers)Yan Huang (4 shared papers)Shiyang Kang (3 shared papers)Nan Chen (3 shared papers)Yaxiong Zhang (2 shared papers)Tao Qin (2 shared papers)
- Journals
- Journal of Cancer (3 papers)Frontiers in Oncology (3 papers)Medicine (2 papers)SLAS DISCOVERY (2 papers)Pancreas (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Xiaobo He
68 papers receiving 1.8k citations
Xiaobo He's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 766
- Cancer Research 246
- Pulmonary and Respiratory Medicine 421
- Immunology 228
- Molecular Biology 488
Countries citing papers authored by Xiaobo He
This map shows the geographic impact of Xiaobo He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo He more than expected).
Fields of papers citing papers by Xiaobo He
This network shows the impact of papers produced by Xiaobo He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo He. The network helps show where Xiaobo He may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation Hit paper breakdown → | 2015 | 540 |
| 2 | 2015 | 106 | |
| 3 | 2021 | 63 | |
| 4 | 2015 | 61 | |
| 5 | 2010 | 59 | |
| 6 | 2014 | 56 | |
| 7 | 2017 | 50 | |
| 8 | 2004 | 49 | |
| 9 | 2017 | 49 | |
| 10 | 2015 | 44 | |
| 11 | 2016 | 39 | |
| 12 | 2013 | 38 | |
| 13 | Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells. | 2017 | 38 |
| 14 | 2017 | 33 | |
| 15 | 2009 | 31 | |
| 16 | 2016 | 28 | |
| 17 | 2011 | 26 | |
| 18 | SOX2 inhibits cell proliferation and metastasis, promotes apoptotic by downregulating CCND1 and PARP in gastric cancer. | 2018 | 25 |
| 19 | 2020 | 22 | |
| 20 | 2019 | 21 |
About Xiaobo He
Xiaobo He is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 69 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Bone Metabolism and Diseases (8 papers), Bone health and osteoporosis research (5 papers), Renal cell carcinoma treatment (4 papers), Pancreatitis Pathology and Treatment (4 papers), TGF-β signaling in diseases (4 papers), Bone health and treatments (4 papers) and Biomarkers in Disease Mechanisms (3 papers). The work is most often cited by research in Oncology (766 citations), Cancer Research (246 citations), Pulmonary and Respiratory Medicine (421 citations), Immunology (228 citations) and Molecular Biology (488 citations). Xiaobo He has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Shaodong Hong, Wenfeng Fang, Jianhua Zhan, Yan Huang, Shiyang Kang, Nan Chen, Yaxiong Zhang, Tao Qin, Yanna Tang and Ting Zhou. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, Medicine, SLAS DISCOVERY and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.